Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma. | Vaccines (Basel) | 2023 | 36992083 | PubTator, text mining | PubMed |
| Exploration and analysis of differentially expressed genes in Epstein-Barr virus negative and positive plasmablastic lymphoma. | Clin Transl Oncol | 2023 | 36991219 | PubTator, text mining | PubMed |
| [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 36987724 | PubTator, text mining | PubMed |
| Past, Present, and a Glance into the Future of Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2023 | 36986514 | PubTator, text mining | PubMed |
| Epigenetic Modifications Induced by the Gut Microbiota May Result from What We Eat: Should We Talk about Precision Diet in Health and Disease? | Metabolites | 2023 | 36984815 | PubTator, text mining | PubMed |
| Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma. | J Clin Med | 2023 | 36983174 | PubTator, text mining | PubMed |
| Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia. | Genes (Basel) | 2023 | 36980827 | PubTator, text mining | PubMed |
| The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies. | Cancers (Basel) | 2023 | 36980798 | PubTator, text mining | PubMed |
| Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. | Cancers (Basel) | 2023 | 36980732 | PubTator, text mining | PubMed |
| The Potential Revolution of Cancer Treatment with CRISPR Technology. | Cancers (Basel) | 2023 | 36980699 | PubTator, text mining | PubMed |
| The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? | Cancers (Basel) | 2023 | 36980665 | PubTator, text mining | PubMed |
| Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma. | Transl Res | 2023 | 36977441 | PubTator, text mining | PubMed |
| Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer. | Oncoimmunology | 2023 | 36970072 | PubTator, text mining | PubMed |
| Regulation of CD8 T cell by B-cells: A narrative review. | Front Immunol | 2023 | 36969196 | PubTator, text mining | PubMed |
| CD27+ microparticle interactions and immunoregulation of CD4+ T lymphocytes. | Front Immunol | 2023 | 36969173 | PubTator, text mining | PubMed |
| An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. | Front Oncol | 2023 | 36969014 | PubTator, text mining | PubMed |
| Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic. | Front Immunol | 2023 | 36960050 | PubTator, text mining | PubMed |
| Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. | Front Immunol | 2023 | 36949954 | PubTator, text mining | PubMed |
| Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells. | Front Immunol | 2023 | 36949949 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=41